Thursday, May 24, 2018 10:39:36 AM
Recent DERM News
- Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer • GlobeNewswire Inc. • 05/01/2024 08:01:30 PM
- Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 • GlobeNewswire Inc. • 04/25/2024 12:30:48 PM
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/21/2024 08:01:27 PM
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea • GlobeNewswire Inc. • 03/18/2024 12:30:30 PM
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 12:30:01 PM
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/13/2024 12:30:14 PM
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:30:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:54:53 PM
- Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 01/05/2024 01:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:05:34 PM
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million • GlobeNewswire Inc. • 01/02/2024 09:05:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/15/2023 09:46:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:01:17 PM
- Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 12/06/2023 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:45:43 PM
- Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 11/07/2023 09:01:18 PM
- Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 • GlobeNewswire Inc. • 10/31/2023 12:30:12 PM
- Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) • GlobeNewswire Inc. • 10/20/2023 12:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 01:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 08:59:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 05:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:00:22 PM
- Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations • GlobeNewswire Inc. • 09/06/2023 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:00:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM